Radosław Kitel

940 total citations · 1 hit paper
20 papers, 712 citations indexed

About

Radosław Kitel is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Radosław Kitel has authored 20 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Radosław Kitel's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (3 papers) and Synthesis and biological activity (2 papers). Radosław Kitel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (3 papers) and Synthesis and biological activity (2 papers). Radosław Kitel collaborates with scholars based in Poland, Germany and Netherlands. Radosław Kitel's co-authors include Tad A. Holak, Bogdan Musielak, Alexander Dömlingꝉ, Grzegorz Dubin, Przemysław Golik, Krzysztof M. Żak, Katarzyna Guzik, Sara Przetocka, Katarzyna Magiera‐Mularz and Ewa Surmiak and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Radosław Kitel

19 papers receiving 703 citations

Hit Papers

Structure of the Complex of Human Programmed Death 1, PD-... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radosław Kitel Poland 11 452 240 228 118 95 20 712
Tracey Clark United States 17 440 1.0× 179 0.7× 578 2.5× 413 3.5× 102 1.1× 22 1.1k
Markella Konstantinidou Netherlands 12 279 0.6× 94 0.4× 471 2.1× 63 0.5× 250 2.6× 21 810
Ben‐Fillippo Krippendorff Switzerland 11 189 0.4× 124 0.5× 439 1.9× 257 2.2× 51 0.5× 17 763
Xiujun Liu China 18 268 0.6× 125 0.5× 472 2.1× 63 0.5× 155 1.6× 61 832
Yangping Wu China 14 244 0.5× 124 0.5× 509 2.2× 64 0.5× 212 2.2× 22 933
Rosalinda Syto United States 11 320 0.7× 144 0.6× 569 2.5× 63 0.5× 96 1.0× 16 809
Murray McKinnon United States 17 117 0.3× 284 1.2× 469 2.1× 85 0.7× 177 1.9× 35 902
Aaron D. Schuler United States 11 192 0.4× 74 0.3× 552 2.4× 45 0.4× 100 1.1× 17 975
Flora Huang United States 17 209 0.5× 275 1.1× 695 3.0× 572 4.8× 47 0.5× 32 1.0k
Matthew Labenski United States 12 166 0.4× 70 0.3× 405 1.8× 68 0.6× 200 2.1× 20 701

Countries citing papers authored by Radosław Kitel

Since Specialization
Citations

This map shows the geographic impact of Radosław Kitel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radosław Kitel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radosław Kitel more than expected).

Fields of papers citing papers by Radosław Kitel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radosław Kitel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radosław Kitel. The network helps show where Radosław Kitel may publish in the future.

Co-authorship network of co-authors of Radosław Kitel

This figure shows the co-authorship network connecting the top 25 collaborators of Radosław Kitel. A scholar is included among the top collaborators of Radosław Kitel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radosław Kitel. Radosław Kitel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skalniak, Łukasz, et al.. (2024). An updated patent review on PD-1/PD-L1 antagonists (2022-present). Expert Opinion on Therapeutic Patents. 34(8). 627–650. 9 indexed citations
2.
Kitel, Radosław, et al.. (2024). Nonsymmetrically Substituted 1,1′-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction. ACS Medicinal Chemistry Letters. 15(6). 828–836. 3 indexed citations
3.
Siebenmorgen, Till, Filipe Menezes, Erinç Merdivan, et al.. (2024). MISATO: machine learning dataset of protein–ligand complexes for structure-based drug discovery. Nature Computational Science. 4(5). 367–378. 27 indexed citations
4.
Tormo, José R., Víctor González-Menéndez, Thomas A. Mackenzie, et al.. (2024). Discovery of bioactive natural products of microbial origin as inhibitors of the PD-1/PD-L1 protein-protein interaction. International Journal of Biological Macromolecules. 264(Pt 1). 130458–130458. 1 indexed citations
5.
Kitel, Radosław, Ewa Surmiak, Jan Borggräfe, et al.. (2023). Discovery of Inhibitory Fragments That Selectively Target Spire2–FMN2 Interaction. Journal of Medicinal Chemistry. 66(23). 15715–15727.
6.
Rubner, Stefan, Przemysław Golik, Ewa Surmiak, et al.. (2023). Nutlin‐3a‐aa: Improving the Bioactivity of a p53/MDM2 Interaction Inhibitor by Introducing a Solvent‐Exposed Methylene Group. ChemBioChem. 24(6). e202300006–e202300006. 5 indexed citations
7.
Kitel, Radosław, Ewa Surmiak, Katarzyna Magiera‐Mularz, et al.. (2022). Exploring the Surface of the Ectodomain of the PD-L1 Immune Checkpoint with Small-Molecule Fragments. ACS Chemical Biology. 17(9). 2655–2663. 12 indexed citations
8.
Crevenna, Álvaro H., Radosław Kitel, Kherim Willems, et al.. (2022). Analysis tools for single-monomer measurements of self-assembly processes. Scientific Reports. 12(1). 4682–4682. 2 indexed citations
9.
Kitel, Radosław, et al.. (2022). Hexokinase 2 Inhibition and Biological Effects of BNBZ and Its Derivatives: The Influence of the Number and Arrangement of Hydroxyl Groups. International Journal of Molecular Sciences. 23(5). 2616–2616. 11 indexed citations
10.
Surmiak, Ewa, Katarzyna Magiera‐Mularz, Bogdan Musielak, et al.. (2021). PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action. International Journal of Molecular Sciences. 22(21). 11797–11797. 27 indexed citations
11.
Surmiak, Ewa, Jacek Plewka, Katarzyna Magiera‐Mularz, et al.. (2021). Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein–Protein Interaction. Journal of Medicinal Chemistry. 64(15). 11614–11636. 61 indexed citations
12.
Karim, A., Przemysław Golik, Radosław Kitel, et al.. (2021). Structural Determinants of Substrate Specificity of SplF Protease from Staphylococcus aureus. International Journal of Molecular Sciences. 22(4). 2220–2220. 10 indexed citations
13.
Kitel, Radosław, et al.. (2021). Effect of Selected Silyl Groups on the Anticancer Activity of 3,4-Dibromo-5-Hydroxy-Furan-2(5H)-One Derivatives. Pharmaceuticals. 14(11). 1079–1079. 14 indexed citations
14.
Butera, Roberto, Katarzyna Magiera‐Mularz, Jacek Plewka, et al.. (2021). Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists. ACS Medicinal Chemistry Letters. 12(5). 768–773. 44 indexed citations
15.
Zdzalik, Michal, Radosław Kitel, A. Karim, et al.. (2018). Unique Substrate Specificity of SplE Serine Protease from Staphylococcus aureus. Structure. 26(4). 572–579.e4. 25 indexed citations
17.
Żak, Krzysztof M., Radosław Kitel, Sara Przetocka, et al.. (2015). Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1. Structure. 23(12). 2341–2348. 413 indexed citations breakdown →
18.
Szeja, Wiesław, et al.. (2014). Synthesis and Cytotoxicity of 2,3-Enopyranosyl C-Linked Conjugates of Genistein. Molecules. 19(6). 7072–7093. 15 indexed citations
19.
Kitel, Radosław, Joanna Czarnecka‐Herok, & Aleksandra Rusin. (2013). [Three-dimensional cell cultures. Applications in basic science and biotechnology].. PubMed. 59(3). 305–14. 4 indexed citations
20.
Rusin, Aleksandra, et al.. (2013). Synthesis of genistein 2,3-anhydroglycoconjugates -- potential antiproliferative agents.. PubMed. 69(6). 1239–47. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026